Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer

Biomedicine and Pharmacotherapy

Volumn 66, Issue 6, 2012, Pages 474-483

  Nadda, N ^a   Vaish, V ^a   Setia, S ^a   Sanyal, S N ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Angiogenesis; Chemokines; NSAIDs

Indexed keywords

ANGIOGENESIS INHIBITOR; BETA ACTIN; CARBOXYMETHYLCELLULOSE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIMETHYLBENZ[A]ANTHRACENE; ETORICOXIB; GELATINASE A; GELATINASE B; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MEROCYANINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOKINES; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MATRIX METALLOPROTEINASES, SECRETED; MEMBRANE FLUIDITY; NEOVASCULARIZATION, PATHOLOGIC; PYRIDINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SULFONES; TUMOR BURDEN;

EID: 84866173276     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.04.002     Document Type: Article

References (42)

1. Billing P.C., Habres J.M., Liao D.C., Tuttle S.W. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 1991, 51:5539-5543.
2. Contois L., Akalu A., Brooks P.C. Integrins as functional hubs in the regulation of pathological angiogenesis. Semin Cancer 2009, 19:318-328.
3. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumoriogenesis. Cell 1996, 86:353-364.
4. Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992, 267:10931-10934.
5. Yano S., Nishioka Y., Goto H., Sone S. Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules. Cancer Sci 2003, 94:479-485.
6. Folkman J., Klagsburn M. Angiogenic factors. Science 1987, 235:442-447.
7. Kandel J., Bossy-Wetzel E., Radvanyi F. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991, 66:1095-1104.
8. Gridelli C., Maione P., Airoma G., Rossi A. Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer. Curr Med Chem 2002, 9:1851-1858.
9. Deryugina E.I., Quigley J.P. Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta 2010, 1803:103-120.
10. Shaykhiev R., Krause A., Salit J., Strulovici-Barel Y., Harvey B.G., O'Connor T.P., Crystal R.G. Smoking-dependent reprogramming of alveolar macrophage polarization: Implication for pathogenesis of COPD. J Immunol 2009, 183:2867-2883.
11. Monton C., Torres A. Lung inflammatory response in pneumonia. Monaldi Arch Chest Dis 1998, 53:56-63.
12. Saini R.K., Sanyal S.N. Pulmonary carcinogenesis in mice with a single intratracheal instillation of 9,10-dimethyl benz(a)anthracene. Drug Chem Toxicol 2008, 31:459-471.
13. Sharma P., Kaur J., Sanyal S.N. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model. Nutr Hosp 2010, 25:39-48.
14. Saini R.K., Sanyal S.N. Chemopreventive effect of nonsteroidal anti-inflammatory drugs on 9,10-Dimethylbenz[a]anthracene-induced lung carcinogenesis in mice. Oncol Res 2009, 17:505-518.
15. Thakur P., Sanyal S.N. Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac. Exp Mol Pathol 2010, 88:394-400.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
17. Lehrach H., Diamond D., Wozney J.M., Boedtker H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 1977, 16:4743-4751.
18. Baumber J., Meyers S.A. Changes in membrane lipid order with capacitation in rhesus macaque (Macaca mulatta) spermatozoa. J Androl 2006, 27:578-587.
19. Li N., Chen X., Liao J., Yang G., Wang S., Josephson Y., Chi H., Chen J., Huang M.T., Yang C.S. Inhibition of 7,12-dimethyl benz(a)anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 2003, 23:1307-1313.
20. N'jai A.U., Larsen M., Shi L., Jefcoate C.R., Czuprynski C.J. Bone marrow lymphoid and myeloid progenitor cells are suppressed in 7, 12-dimethylbenz(a)anthracene (DMBA) treated mice. Toxicology 2010, 271:27-35.
21. Thakur P., Sanyal S.N. Chemopreventive role of preferential COX-2 inhibitor diclofenac in 9, 10- Dimethybenz(a)anthracene induced experimental lung carcinogenesis. Am J Biomed Sci 2010, 2:275-288.
22. Zimmermann K.C., Sarbia M., Weber A.A., Brochard F., Gabbert H.E., Schror K. Cyclooxygenase expression in human carcinoma. Cancer Res 1999, 59:486-492.
23. Thakur P., Sanyal S.N. Chemopreventive action of diclofenac in dimethyl benzanthracene induced lung cancer in female wistar rat. J Environ Pathol Toxicol Oncol 2010, 29:255-265.
24. Hillario N.O.E., Terrari M.T., Len C.A. Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors. J Pediatr (Rio J) 2006, 82:206-212.
25. Petkova D.K., Clelland C., Ronan J., Pang L., Coulson J.M., Lewis S., Knox A.J. Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir Med 2004, 98:164-172.
26. Brooks P., Kubler P. Etoricoxib for arthritis and pain management. Ther Clin Risk Manage 2006, 2:45-57.
27. Matrisian L.M. The matrix degrading metalloproteinases. Bioessays 1992, 14:455-463.
28. Hillion J., Wood L.J., Mukherjee M., Bhattacharya R., Cello F.D., Kowalski J., Elbahloul O., Segal J., Poirier J., Rudin C.M., Dhara S., Belton A., Joseph B., Zucker S., Resar L.M.S. Up-regulation of MMP-2 by HMGA1 promotes transformation in undifferentiated large cell lung cancer. Mol Cancer Res 2009, 7:1803-1812.
29. Miller T.W., Isenberg J.S., Roberts D.D. Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev 2009, 109:3099-3124.
30. Li W.W., Li V.W., Hutnik M., Chiou A.S. Tumor angiogenesis as a target for dietary cancer prevention. J Oncol 2012, 2012:879623.
31. Snoek-van Beurden P.A., Von den Hoff J.W. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques 2005, 38:73-83.
32. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., Oppenheim J.J., Murphy W.J. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96:34-40.
33. Luo X., Yu Y., Liang A., Xie Y., Liu S., Guo J., Wang W., Qi R., An H., Zhang M., Xu H., Guo Z., Cao X. Intratumoral expression of MIP-1β induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells. Cell Mol Immunol 2004, 1:199-204.
34. Sallusto F., Mackay C.R. The role of chemokine receptors in primary effector and memory immune responses. Annu Rev Immunol 2000, 18:593-620.
35. Chaffin K.E., Perlmutter R.M. A pertussis toxin-sensitive process controls thymocyte emigration. Eur J Immunol 1991, 21:2565-2573.
36. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., Imai T., Yoshie O., Bonecchi R., Mantovani A. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998, 161:1083-1086.
37. Roth S.J., Woldemar Carr M., Springer T.A. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-(inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol 1995, 25:3482-3488.
38. Taub D.D., Snayer T.J., Carter C.R., Ortaldo J.R. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995, 155:3877-3888.
39. Chen Y., Mak N.K., Leung W.N., Chen S.C., Leung K.N., Cheung N.H. A study of the binding of merocyanine 540 to myeloid leukemia M1 cells using an intensified charge-coupled device for fluorescence imaging microscopy. J Photochem Photobiol 1997, 39:49-55.
40. Zhou Y., Hancock J.F., Lichtenberger L.M. The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membrane potential implication for its diverse biological action. PLoS One 2010, 5:e8811.
41. Lagerberg J.W., Kallen K.J., Haest C.W., VanSteveninck J., Dubbelman T.M. Factors affecting the amount and the mode of merocyanine 540 binding to the membrane of human erythrocytes. A comparison with the binding to leukemia cells. Biochim Biophys Acta 1995, 1235:428-436.
42. Kalyanaraman B., Feix J.B., Sieber F., Thomas J.P., Girotti A.W. Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen. Proc Natl Acad Sci U S A 1987, 84:2999-3003.